-
Cost of extended drug patents pegged at $270M a year for feds, $392M for Canadians
An extension of drug patent protections in the Canada-EU free trade deal could end up costing Canadians an estimated $392 million a year, and federal coffers up to $270 million more annually, says a new report from the parliamentary budget officer.